Results 51 to 60 of about 77,151 (268)
Revista Alergia México, 2015 Mastocytosis is one of the eight subcategories of the myeloproliferative neoplasms of the classification of lymphoid and hematopoietic tissues’ tumors of 2008 of World Health Organization; it is an heterogeneous group of myeloproliferative diseases characterized by the excessive proliferation of atypical mastocytes in morphological and immunophenotype ...
González Díaz, Sandra Nora +3 more
openaire +3 more sources
Bullous mastocytosis: a Case Report
Journal of the Egyptian Women’s Dermatologic SocietyMastocytosis is a disorder characterized by abnormal mast cell proliferation. The skin is the most common site of involvement. Extracutaneous involvement occurs in systemic mastocytosis with infiltrations in the gastrointestinal tract, lymph nodes, bone ...
Galal El Enany +7 more
doaj +1 more source
Klinikai tapasztalataink cutan mastocytosisban. [PDF]
, 2013 Introduction: Mastocytosis is a clonal mast cell proliferative disease, devided into cutaneous and systemic forms. The characteristic symptoms are caused by neoplastic mast cell infiltrations in different organs and/or the release of mediators.
Csomor, Judit +7 more
core +1 more source
Drug hypersensitivity reactions and allergy in patients with mastocytosis
Przegląd Dermatologiczny, 2017 Mastocytosis is a rare myeloproliferative disease caused by excessive proliferation and accumulation of mast cells in the skin and internal organs. The most common variant of mastocytosis in children is cutaneous mastocytosis.
Justyna H. Czarny +7 more
doaj +1 more source
Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease [PDF]
, 2014 BACKGROUND: Mastocytosis is a clonal disorder characterized by the accumulation of abnormal mast cells in the skin and/or in extracutaneous organs. OBJECTIVES: To present all cases of mastocytosis seen in the Porto Hospital Center and evaluate the ...
Alves, R. +5 more
core +1 more source
Allergy, EarlyView.This study investigates the effect of IL‐33 and Hymenoptera venom on mast cell cytokine profiles under venom immunotherapy (VIT)‐like conditions. Our in vitro model of VIT‐like mast cell stimulation demonstrates a modulatory effect of IL‐33 on the secreted mast cell cytokine profile.
Andrea R. Teufelberger +3 more
wiley +1 more source
Epidemiology of mastocytosis: a population-based study (Sweden)
Acta OncologicaBackground: Mastocytosis is a disease characterized by accumulation of aberrant mast cells and mediator-related symptoms and is divided into systemic mastocytosis (SM) and cutaneous mastocytosis (CM).
Anna Bergström +4 more
doaj +1 more source
The Basophil Activation Test Is Not a Useful Screening Tool for Hymenoptera Venom-Related Anaphylaxis in Patients with Systemic Mastocytosis [PDF]
, 2016 Background: Systemic mastocytosis (SM) patients are at a high risk for anaphylaxis, with Hymenoptera as the main culprit. A screening instrument to identify which patients are sensitized to Hymenoptera before they experience anaphylaxis would therefore ...
Daele, P.L.A. (Paul) van +4 more
core +1 more source
Pseudoxanthomatous mastocytosis [PDF]
International Journal of Dermatology, 2007 A 50‐year‐old woman presented with itchy, multiple, flat, yellowish, waxy papules and plaques diffusely involving her face, trunk, and upper extremities for 5 years (Fig. 1). Itching was moderate to severe in intensity and was episodic, without any identifiable aggravating or relieving factors.
Neeraj, Srivastava +2 more
openaire +2 more sources
Comprehensive mastocytosis data analysis from a single center
BMC Cancer, 2023 Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma or localized mast cell (MC) tumors.
Tarık Onur Tiryaki +11 more
doaj +1 more source